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Abstract
It has recently been discovered that the digestive tract is lined with about 100 million 
nerve cells; the digestive tract has been baptized, metaphorically speaking, as “the second 
brain,” which contains a multitude of neurotransmitters, viruses, and bacteria that help 
regulate our emotional state. This second brain, known as the enteric nervous system, 
is a unique anatomical unit that extends from the esophagus to the anus. Like the ner-
vous system, it produces a whole series of psychoactive substances, such as serotonin, 
dopamine, and opioids for pain, and synthesizes benzodiazepines. In it, we find the 
microbiota: a set of microorganisms (viruses and bacteria). Together with the brain, the 
microbiota directly influences mood, character, or sleep. Knowledge about the possible 
relationship of the microbiota with frequent neurological diseases is still just beginning. 
Recently, possible changes in the microbiota have been linked to the onset of Parkinson’s 
disease (PD). Also, today, we know that there are differences between the microbiota of 
healthy people and people with multiple sclerosis and that these differences have also 
been related to the disease and its evolution.
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1. Introduction
Currently, we know that the enteric nervous system, although it has a certain sovereignty 
or autonomy, will always need to communicate with other systems in order to carry out 
functions of its authorship or of other adjacent systems. Thus, in a classical way, the enteric 
nervous system interacts with the central nervous system but also exhibits a certain exchange 
of stimuli with other systems. Through this connection afferent and efferent responses are 
generated, with the consequent exchange of information. Remember that the afferent neurons 
send information of the intraluminal chemical content, mechanical state of the intestinal wall, 
and tissue situation (inflammation, pH, cold, and heat) to the central nervous system. The 
responses follow an extrinsic efferent pathway where the main neurotransmitter is norepi-
nephrine. In addition, the efferent neurons come from the prevertebral nodes that control 
motility and secretion and the paravertebrals that control the flow of gastrointestinal blood 
vessels. Also, the relaxation of the gastric fundus and gastric and pancreatic secretion is medi-
ated through vagal neurons. In contrast to what happens in the upper digestive tract, the 
distal colon and rectum are innervated by pelvic nerves. In general, vagal stimulation inhibits 
motor activity, gastrointestinal secretion, sphincter contraction, and blood flow, while, on the 
contrary, spinal stimulation stimulates them. The responses may have extrinsic afferent path-
ways where spinal and vagal reflexes are also activated. The primary afferent vagal neurons 
have their cell bodies in the nodosum and jugular ganglia and project medially to the brain, 
while the spinal neuronal bodies are found in the roots of the dorsal ganglia. The vagal path-
ways transmit information about the physiological state of the digestive organs and regulate 
inflammatory responses, while the spinal pathways transmit the painful impulses.
2. Gut microbiota
Since 2007, the genome of 500 bacterial species that normally reside in the human intestine, 
and which together are known as microbiome or microbiota, has been identified. Our intes-
tinal tract contains over 100 billion microbes, the vast majority in the colon, exceeding the 
number of human cells by a factor [1]. This complex microbial community is known as the 
gastrointestinal microbiota, and it consists of bacteria, archaea, eukaryotes, fungi, and viruses. 
Therefore, it has been proposed that the human being is a “meta-organism” with 10–100 times 
more bacterial than human cells, which integrate metabolically and immunologically. The 
composition of the microbiota, in addition to location, is influenced by age, sex, race, and 
other factors like diet, medication (especially antibiotics), stress, smoking, or gastrointesti-
nal infections, as well as from each individual [2]. Even within each person, there are great 
variations in their composition if measured at different times. Although it is impossible to 
define the concept of healthy microbiota today, we do know that the richness and diversity 
of the microbiota are indicators of its health and that its impoverishment is associated with 
obesity and metabolic markers [2]. As for the qualitative composition, numerous studies 
are emerging that try to relate certain classes of microorganisms with different physiologi-
cal states. It is proposed that there are those that improve the metabolic state, resistance to 
infections, cancer, autoimmunity, inflammation, endocrine signaling, and brain functionality 
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(gut-brain axis): Bacteroides, Bifidobacterium, Clostridium group XIVa and IVa (butyrate pro-
ducing), Eubacterium, Faecalibacterium, Lactobacillus, and Roseburia are considered today [3]. 
The relationship between the microbiota and the human being has been redefined from com-
mensal to a mutualist relationship, where the bacteria provide biological functions not coded 
genetically in our organism, which go from metabolic activity to immunological homeostasis, 
considering the microbiota as a fundamental, virtual organ in the pathophysiological and 
immunological responses. There are studies related to the role of the intestinal microbiota in 
human health, infections, and neurological diseases [4] (Figure 1).
It has rarely been thought that microorganisms and the brain interact except in instances 
where pathogens penetrate the blood-brain barrier, which is the cellular strength that protects 
the brain from infections and inflammation [5]. When they do, they can have strong effects. 
Bidirectional communication between the brain-nervous system and the microbiota is well 
known in specific cases. Pavlov’s experiments showed how a sound processed by the brain 
can condition the physiology of the digestive system, stimulating, among other things, gastric 
secretion [6].
Clostridium botulinum can colonize the intestine and from there release its toxin that blocks 
the release of acetylcholine at the neuromuscular synapse. In the case of hepatic encepha-
lopathy, brain dysfunction is a consequence of substances produced in the intestine, and its 
treatment includes the use of antibiotics and probiotics [7]. Certain autoimmune neurological 
diseases, such as Guillain-Barré syndrome, may have their origin in certain intestinal bacteria 
and Campylobacter jejuni. The virus that causes rabies generates aggression, agitation, and 
even a fear of water, but for decades the vast majority of the body’s natural microbes had not 
Figure 1. The composition of the intestinal microbiota is influenced by physicochemical conditions and also depends on 
the anatomical region along the GI. The type and number of microbial species that persist and colonize the GI tract are 
determined by a combination of factors including but not limited to the host genetics, medications, diet, environmental 
factors, and to the inflammatory state of the host. In elderly patients, we can observe changes in the composition of the 
microbiota in comparison to young people, which could lead to a dysbiosis.
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been described, and while the idea that they could influence neurobiology hardly prevailed, 
that is slowly changing [8]. On the other hand, metabolic functions include the degradation 
of polysaccharides to short-chain fatty acids, such as butyrate, propionate, and acetate, with 
anti-inflammatory properties and the main energetic substrate of colonocytes, and thus are 
implicated in the barrier function of the gut mucosa [9]. Some bacteria, particularly lactobacilli, 
have been implicated in cholesterol metabolism and in the production of vitamins K and B 
and are also involved in the metabolism of xenobiotics, drugs, antibiotics, or bioactive prod-
ucts, conditioning pharmacokinetics, and the production of certain toxins involved in many 
diseases [9].
2.1. Microbiota and immune response
The microbiota contributes to various immunological functions. In the gut barrier, it prevents 
colonization and growth of pathogenic microorganisms, and it matures the immune barrier, 
both stimulating the innate response through Toll-like receptors (TLR) and NOD-like recep-
tors (NLR) as the adaptive one, with an important role in the secretion of mucins, antimicro-
bial peptides, defensins, and IgA [10]. Regarding the development of the systemic immune 
response, in working with germ-free mice, the microbiota has been observed to intervene in 
the regulation and maturation of Peyer’s plaques, mesenteric lymph nodes, and germinal 
centers [11]. It also regulates the number of plasma cells producing IgA, gut Tγδ cells, and 
CD4 + T lymphocytes in the lamina propria or intraepithelial and is involved in the gene 
expression of TLR and the major histocompatibility complex II [12]. The microbiota also con-
ditions the development of effector T cells and the production of cytokines, highlighting the 
influence on Th and Treg lymphocytes involved in the autoimmune response and its regula-
tion and, therefore, in autoimmune diseases in general and in multiple sclerosis in particular 
[13]. Germ-free mice (mice raised to lack intestinal microbiota) present a reduction in Th1 and 
Th lymphocytes, balancing the T-immune response to Th, which is reversed by reconstitut-
ing the normal gut microbiota in these animals. It has been proposed that the microbiota is 
involved in the passage of stationary T lymphocytes to pro-autoimmune T lymphocytes, so 
that mutualist microorganisms induce the production of Th at a steady state, which, in the 
presence of a proinflammatory microenvironment, promoted by certain cytokines such as IL- 
12, IL-23, IL-1β, or TGF-β3, would pass to pathogenic Th, a producer of IFN-γ, contributing 
to the progression of the inflammatory bowel environment [14]. It has been shown that the 
involvement of a single bacterium, the segmented filamentous bacteria, can contribute to this 
Th pro-autoimmune activity [14] (Figure 2).
As for the Treg, the microbiota is indispensable for its development and function. These lym-
phocytes regulate the inflammation that is generated against microbial stimuli through IL-10 
[15]. Numerous microbial agents have been linked to the induction of Treg, notably the role 
of Bacteroides fragilis and specifically its polysaccharide A (PSA) with the development of IL-10 
producing Foxp3+ regulatory T cells and with the prevention and cure of experimental colitis 
or shock in animal models, showing its key role in the regulation of immunological tolerance 
[16]. The aforementioned short-chain fatty acids, especially butyrate, balance the immune sys-
tem to an “anti-inflammatory state” by increasing the production of IL-10 and IL-4, reducing 
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vascular adhesion of VCAM-mediated leukocytes, inhibiting function of IFN-γ and therefore 
its proinflammatory capacity, and regulating the Treg lymphocytes and the inflammatory 
function of leukocytes [17] (Figure 3).
2.2. Gut and nervous system
The surface of the gut mucosa is the most extensive of the organism and also houses the 
largest number of lymphoid structures in the human body. The innervations of the digestive 
tract are very abundant and are structured in three levels of plexus: functions of the enteric 
autonomic nervous system include bowel motility, vaso-regulation and permeability control, 
and secretion of certain gastroenteropancreatic hormones [18]. In addition, similar to what 
occurs in the blood-brain barrier, there are numerous astrocyte terminations at the border of 
the intestinal barrier that represent a potential pathway for communication with the rest of the 
nervous system. In the intestine we have about 100 million neurons, which are more than the 
spinal cord contains [19]. This multitude of neurons in the enteric nervous system allows us to 
feel the inner world of our gut and its contents. Much of this neuronal arsenal is evidenced in 
the elaborate daily routine of digestion, through decomposing food and absorbing nutrients. 
Expelling waste requires chemical, mechanical, and rhythmic muscle contractions that move 
everything to the end. Therefore, equipped with its own reflexes and senses, it can control the 
behavior of the gut independently of the brain. This nervous system of the intestine is con-
nected to the brain in a bidirectional way. On one hand, the bowel receives information from 
the brain, and on the other hand, the bowel sends messages to the brain [20]. This communica-
tion of the intestine with the brain occurs both through the nervous system and the blood-
stream and is called the gut-brain axis. Typical examples of this bidirectional circuit would 
be the increase in intestinal peristalsis (colicky pain and diarrhea) when our brain perceives a 
Figure 2. Microbiota stimulation leads to B cell switch to lga, regulatory T-cell induction, and T-cell differentiation 
to Th17. This image is a modification of QIAGEN’s original at www.qiagen.com/mx/shop/genes-and-pathways/
pathway-details/?pwid=468.
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danger or, in the opposite direction, the sensation of satiety that our brain perceives when we 
have ingested a certain quantity of food [20] (Figure 4).
The intestine, besides having a nervous system of its own, is also an ecosystem. Colonization 
by the intestinal microbiota affects the brain development of mammals and their behavior 
during adulthood [21]. Through measurements of motor activity and behavior related to 
anxiety, it has been demonstrated in mice that the microbial colonization process triggers 
signaling mechanisms that affect these neural circuits, so that the gut microbiota can influence 
normal brain development and behavioral functions [22], and the microbiota is capable of 
modifying the expression of some risk genes or is part of the mechanisms that alter the cogni-
tive functions observed in patients with gastrointestinal diseases [22]. The alteration of this 
microbiota and gut-brain axis could explain some of the mechanisms of the pathogenesis of 
diverse cerebral diseases like, for example, Parkinson’s disease, multiple sclerosis, depression, 
Alzheimer’s disease, etc., although today its etiology still remains unknown [23]. In studies 
in mice, it has been shown that alterations in the intestinal microbiota could be responsible 
for alterations in social behavior and that supplementation with probiotics such as B. fragilis 
administered in the early stages of adolescence in mice could reduce brain alterations [23]. But 
the influence of the microbiota on the brain is unknown in detail, beyond the simple examples 
previously uncovered, which do not reflect the full extent of this relationship. Much more 
articulate is the observation of what happens to mice whose digestive tract has remained 
sterile throughout their development as “germ-free” [23]. It has been found that in these ani-
mals the microglia does not mature properly and it is very difficult to provoke experimental 
allergic encephalitis and that these mice also have changes in their behavior, with increased 
responses to stress, and most amazingly, certain areas of their brain, like the amygdala and 
hippocampus, show structural differences.
Figure 3. Regulation of inflammation by Treg, through IL-10 and IL-4 generated against microbial stimuli, Bacteroides 
fragilis specifically its polysaccharide a (PSA).
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Given the role of the vagus nerve in the communication of signals between the gut and the 
brain, many investigations that seek to explore the connections between microorganisms 
and the CNS have examined the function of this nerve. Thus, it has been shown that both 
pathogenic and nonpathogenic bacteria appear to activate the vagus nerve. For example, sub-
diaphragmatic vagotomy attenuates the expression of c-fos in rats inoculated with Salmonella 
typhimurium; the combination of a C. rodentium infection and stress causes an increase in the 
activation of the vagal ganglion in mice; intraduodenal injection of L. lactis La1 activates the 
gastric vagal nerve in rats; subdiaphragmatic vagotomy blocks the anxiolytic and antidepres-
sive effects of the chronic ingestion of L. rhamnosus in normal adult mice while avoiding the 
associated alterations in the expression of GABAAα2 mRNA in the amygdala; and vagotomy 
abolishes the ability of B. longum to attenuate anxiety induced by DSS colitis.
3. The second brain
The relationship between the brain, the emotions, and the digestive tract is intense. So much 
so that many scientists refer to the intestine as the “second brain” or “gut-brain,” since the 
digestive tract contains a very complex neural network with a neuronal function very similar 
to the activity of the head.
The presence of receptors to various neurotransmitters in the intestine has been demonstrated: 
it is known that some intestinal molecules, such as serotonin 5-HT, can modulate the patho-
genic potential of Pseudomonas fluorescens by affecting its motility and pyoverdine production 
but without affecting its growth. It has been reported that gut microbiota can control the 
Figure 4. Key aspects of gastrointestinal physiology are controlled by the enteric nervous system, which is composed 
of neurons and glial cells. These cells of the enteric nervous system are connected to the central nervous system (in 
a bidirectional way). As an example, when we ingest food, through neural pathways and immune and endocrine 
mechanisms, we will perceive the sensation of satiety.
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tryptophan metabolism of the host by enhancing the fraction of tryptophan available for the 
kynurenine route and decreasing the amount available for 5-HT synthesis [24]. Free fatty acid 
receptor 3 (FFAR3) receptors for short-chain fatty acids (SCFAs) have been detected in sub-
mucosal and myenteric ganglia, and the responsiveness of enteric neurons to glucose, amino 
acids, and fatty acids has been demonstrated [24]. For example, there are receptors to the 
stress hormones epinephrine and norepinephrine, and this increases by more than four orders 
of magnitude in the human gut in the presence of Clostridium/Bacteroides. A recent report has 
demonstrated that Vibrio cholerae can respond to epinephrine and norepinephrine (enhanc-
ing the growth rate, swimming motility, and production of virulence factors such as iron 
sequestering phenotypes) by means of specific sensor proteins [24]. Less information is avail-
able on prokaryotic Glu receptors; however, 100 prokaryotic channel proteins with putative 
Glu-binding domains have recently been identified through a bioinformatic study. Among 
them, 22 proteins have been found to be homologs of vertebrate ionotropic Glu receptors. 
Multiple Glu receptor types (including ionotropic, types 1 and 4 metabotropic receptors, and 
heterodimeric TAS1R1 + TAS1R3, L-Glu taste receptors) have been detected in gastrointestinal 
(GI) epithelial cells and/or enteric neurons in the stomach, small intestine, and colon. And 
mGlu4 receptors have been detected in the mucosa of both the gastric antrum and duodenum, 
while both mGlu4 and mGlu7 receptors have been identified in the colon epithelium. A role 
of mGluRs in the human colon in the control of colon peristalsis and electrolyte transport has 
been described. High levels of mGlu7 and mGlu8 have been detected in myenteric neurons, 
where they are possibly involved in the regulation of gut motility [24]. The GABA
B
 receptors 
are abundantly expressed in the GI tract. GABA and its ionotropic and metabotropic recep-
tors are widely distributed throughout the ENS, in both submucosal and myenteric neurons, 
from the stomach to the ileum. The release of 5-HT by endothelial cells in the small intestine of 
guinea pig is modulated by GABA
A
 and GABA
B
 receptors. Involvement of GABA
B
 receptors 
in modulation of sensitivity of vagal and spinal afferents has been reported [24].
To think that the intestine acts as a second brain is not something new if we look at the more 
oriental cultures [25]. For them, the belly was and is the center of the vital energy of the organ-
ism where they integrate mind and body. The small brain that we have in the gut works in 
connection with the big brain in the skull and partly determines our mental state and plays a 
key role in certain diseases that affect other parts of the body. In addition to neurons, all types 
of neurotransmitters in the brain are present in the digestive system. The enteric nervous 
system secretes the same substances as those found in our central nervous system. There are 
nerve pathways that specifically connect the brain areas related to our emotions and thoughts, 
the immune system, the endocrine system, and the enteric nervous system to each other. 
When there is a disfunction between any of these conected systems, pathological symptoms 
may appear in any of the others even without direct damage to them [25, 26] (Figure 5).
Is well known that 90% of total body serotonin is synthesized in the intestine and it has a 
direct implication in gastrointestinal physiology. In this sense, our diet is important because 
this serotonin is formed from a tryptophan, an essential amino acid, which is only obtained 
through food. Here we begin to see the relationship between the brain, the intestine, and the 
diet [27].
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3.1. Is the gut autonomous?
The gut has the ability to work in two ways: independently and in connection with the brain. 
This connection to the brain (gut-brain axis) is bidirectional in that it goes from the brain to the 
intestine and vice versa. We have long known that many emotional alterations, psychologi-
cal issues, affect at the intestinal level, such as feelings, sadness, and loss of, or increase in, 
appetite. We mentioned above that serotonin in the intestine works as a neurotransmitter in 
the inhibition of anger, aggression, body temperature, mood, sleep, vomiting, and appetite 
and is responsible for keeping our state of equilibrium in balance (its different levels in our 
organism are related to depression). Here, more than 50% of the activity of dopamine also 
occurs: a neurotransmitter that among its functions regulates the levels of pleasure in our 
brain. Its secretion occurs during pleasant situations and encourages us to seek that activity 
or pleasing occupation. This means that food, sex, and various drugs are also stimulants for 
the secretion of dopamine in the brain in certain areas such as the nucleus accumbens and the 
prefrontal cortex [28].
3.2. Some other interactions in the gut-brain axis
Memory: the protein that burns the body fat is also responsible for memory, which is why 
obese people are more prone to dementia. Well-being: mood is lodged in the stomach since 
90% of serotonin, the “happiness hormone,” is produced and stored there. Sleep: when we 
Figure 5. Second brain. In the intestine we can find neurotransmitters that are exported to the CNS.
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relax the gut, our stomach neurons produce benzodiazepines that relax and induce sleep. 
Stress: in an emergency the brain takes energy from the bowel, and the guts send signals 
like upset stomach. Gluttony: the trillions of bacteria that lodge in the gut choose their own 
nutrients to thrive, and sometimes they are greedier than you. Fear: panic causes the brain to 
frighten the large intestine. It no longer has time to absorb fluid, and the result is diarrhea. 
The relationship between the brain, the microbiota, and the emotions is little investigated. 
There are very preliminary studies. Knowing exactly, at the clinical level, how it can impact 
is difficult to pin down. There are studies that point to the idea of using probiotics as a com-
plementary treatment to drugs that treat anxiety or depressive disorders, as they may help 
amplify the effects, but this is still quite preliminary. Probiotics or foods rich in healthy bacte-
ria, such as yogurts and other fermented milks, exhibited a positive influence on our behavior: 
Lactobacillus and Bifidobacterium bacteria are capable of producing gamma-aminobutyric acid, 
a neurotransmitter of the brain that regulates many psychological processes and whose dys-
function is related to anxiety and depression [29].
4. Neurodegenerative diseases
Knowledge of the possible relationship of the microbiota with frequent neurological diseases 
is still new. Several studies have been carried out to analyze the type of microbiota and many 
neurological diseases. Recently, changes in the microbiota have been linked to the onset of 
Parkinson’s disease (PD). A current theory proposes PD as a disease that progresses paral-
lel to the propagation of insoluble protein accumulations in the nervous system [30]. The 
enteric autonomic nervous system could be one of the starting points of this pathological 
accumulation of proteins, and a change in the microbiota that increases local inflammation 
and oxidative stress could initiate the pathological cascade, similar to what happens in experi-
mental models. In addition, digestive autonomic changes, such as precocious constipation, 
are almost a preclinical constant in PD, and all this would support this hypothesis [31]. In 
certain neurological diseases, immunomodulatory drugs that seek to reestablish a situation 
in which the anti-inflammatory cytokines predominate in the system are used. The important 
relationship of the intestinal microbiota with the immune system offers the possibility of act-
ing on the intestinal bacteria to achieve this change. Experimentally, and through this mecha-
nism, treatment with certain antibiotics has influenced the prognosis of cerebral infarctions in 
experimental animals [32]. It is possible that the lack of knowledge about the etiopathogenesis 
of many neurological diseases and the gut microbiota prevents us from seeing the magnitude 
of the relationship between them and the possibilities of intervention to protect health or 
prevent or ameliorate diseases. Beyond the knowledge of all agents of the microbiota, their 
genes, and their functions, it is even more important to identify the molecules they produce 
and their effects on metabolism. Advances in proteomics and metabolomics with practical 
applications in the daily clinic may be the key to establishing microbiota profiles and the 
different relationships with neuronal diseases [33] (Figure 6).
4.1. Parkinson’s disease
Recently, possible changes in the microbiota have been linked to the onset of Parkinson’s 
disease (PD). A current theory suggests that PD is a disease that progresses parallel to the 
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propagation of accumulations of insoluble proteins in the nervous system. The enteric auto-
nomic nervous system could be one of the starting points of this protein accumulation. A 
change in the microbiota that increased local inflammation and oxidative stress could start 
the pathological cascade, similar to what happens in experimental models of PD. In addition, 
the autonomic changes to digestive disorders, such as precocious constipation, are almost a 
preclinical constant in PD, and all this would support this hypothesis [34]. In Parkinson’s 
disease, a direct correlation between the amount of Enterobacteriaceae microbes in the gut of 
patients, and the degree of severity in the problems of balance and mobility was detected: 
Scheperjans explains that the abundance of Enterobacteriaceae was related to a high degree of 
postural instability and gait difficulty; therefore, there is a connection between the intestinal 
microbiota and the motor symptoms of our patients [35]. The question is, if the differences 
are permanent and whether the intestinal bacteria are linked to the progression of the dis-
ease and therefore to its prognosis. This fact implies that if we can establish the basis of the 
relationship between the intestinal microbiota and PD we will be in a much better posi-
tion for developing new strategies for prevention of the disease and its progression [35, 36]. 
Microbial metabolites have been shown to influence the basic physiology of the blood-brain 
barrier. Intestinal microorganisms break down complex carbohydrates into short chains of 
fatty acids with a set of effects; for example, fatty butyric acid strengthens the blood-brain 
Figure 6. This figure shows the effect of the microbiota on the increased inflammation that results in Parkinson’s disease. 
In addition, the accumulation of insoluble proteins may be an explanation for the pathological accumulation of proteins 
in the nervous system. IP, insoluble protein; NF-kB, nuclear factor kappa enhancer of activated B cells; MAPK, mitogen-
activated protein kinase; P50, cytochromes P450; IKB, inhibitor of kB; IL-8, interleukin 8. This image is a modification of 
QIAGEN’s original at www.QIAGEN.com/es/shop/genes-and-pathways/pathway-details/?pwid=29.
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barrier by adjusting the connections between cells. Also, there are recent studies of neu-
rotransmitters that could enable them to communicate with neurons. For example, it has 
been studied how certain metabolites of the bacterial microbiota promote the production of 
serotonin in the cells lining the colon, an interesting finding given that some antidepressant 
drugs work promoting serotonin at the junctions between neurons [37]. Even though the 
association of gastrointestinal disorders and PD has been studied extensively, it does not 
occur in the same way with the study of the influence of the gut microbiota on PD. The first 
studies in this regard were limited to evaluating the association between Helicobacter pylori 
infestation and PD. These investigations were based on the causal role of H. pylori in a variety 
of human diseases including chronic gastritis, peptic ulcers, and stomach cancer and in the 
well-known association of PD with gastric ulcers [38–41]. Several studies have demonstrated 
the existence of an association between PD and levels of H. pylori infestation. In a small, case-
control study, a fivefold increase in H. pylori antibody levels was observed among patients 
older than 80 years of age with Parkinsonian manifestations [42]. Similarly, in patients with 
PD, a threefold increase in H. pylori antibody levels compared to control subjects has been 
reported. More recently, in an extensive study conducted in Denmark that included a total 
of 4484 PD patients diagnosed between 2001 and 2008, and a total of 22,416 controls, it was 
shown that chronic infections with H. pylori or the presence of gastritis contributed to PD or 
that there are pathologies related to this disease that precede the occurrence of motor symp-
toms. Additionally, it has been shown that the eradication of H. pylori infections decreases 
PD symptoms [43]. Composition of the fecal microbiome has been compared between patients 
with PD and control subjects in the District Hospital of Helsinki and Uusimaa [44]. In this 
study, 72 patients with idiopathic PD and an equal number of control individuals matched 
by sex and age were included. The existence of alterations of the intestinal microbiome in 
patients with PD was demonstrated, and such alterations were associated to the motor phe-
notype. The average abundance of the Prevotellaceae was reduced in 77.6% in the patients 
with PD in comparison with the control subjects. The relative abundance of Prevotellaceae of 
6.5% or less had a sensitivity of 86.1% and a specificity of 38.9%, while a classifier obtained 
by logistic regression based on the abundance of four bacterial families and the severity of 
constipation identified PD patients with a sensitivity of 66.7% and a specificity of 90.3%. On 
the other hand, the relative abundance of Enterobacteriaceae was positively associated with 
the severity of postural instability and difficulty walking. The enterotype of the intestinal 
microbiota represented by Prevotella has been associated with increased levels of short-
chain fatty acids with a neuroactive health-promoting function and with a high capacity 
for the synthesis of thiamine and folate. From these observations, it has been proposed that 
the observed decrease in the abundance of Prevotella could be associated to the previously 
reported decrease in the levels of these vitamins in PD patients and that the supplementa-
tion of these vitamins and short-chain fatty acids may have potential therapeutic effects in 
patients with PD.
4.2. Demyelinating diseases
There is a broad line of research on the relationship between intestinal microbiota and optic 
neuromyelitis and mainly with experimental autoimmune encephalomyelitis (EAE), an ani-
mal model of multiple sclerosis (MS), and an emerging line that is trying to extrapolate the 
results of the EAE to the MS. Patients with aquaporin-positive neuromyelitis optical have a 
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higher serum antibody response to gastrointestinal antigens than healthy controls, especially 
in extensive myelitis, which seems to be related to the control of the microbiota on auto-
immune inflammation [45]. The peripheral existence of aquaporin-specific T cells, capable 
of developing Th responses, which showed cross-reactivity with a homologous sequence in 
an epitope present in Clostridium perfringens, representative of the commensal flora, has also 
been demonstrated, insinuating a mechanism of responsible cellular mimicry of activating 
said Th response [46]. Demyelination usually occurs as a phenomenon secondary to an infec-
tious disorder or a toxin. In the primary demyelinating processes, its cause is unknown, but 
an autoimmune mechanism is thought to occur because its appearance sometimes follows 
a virosis, an antiviral vaccination, or an alteration of the microbiota. Demyelination tends 
to be segmental or patchy and often affects multiple zones at once or in succession. Often 
remyelination occurs, with repair, regeneration, and complete recovery of nerve functions. 
However, any extensive loss of myelin is often followed by axonal degeneration and, often, 
also of cellular soma, and both processes can be irreversible. Demyelination should be con-
sidered for any patient suffering from a neurological deficit without any other explanation. 
Primary demyelinating disorders are suggested by:
• Diffuse or multifocal deficits
• Sudden onset, especially in young adults
• Appearance within weeks after an infection or vaccination
• A course with ups and downs
• Symptoms indicative of a specific demyelinating process (e.g., unexplained optic neuritis 
or internuclear ophthalmoplegia that suggests multiple sclerosis).
4.3. Multiple sclerosis
MS is caused by a combination of genetic and environmental factors. Among the causal fac-
tors, it could be that a certain individual with certain bacterial microbiota could more easily 
develop the disease. However, if we want to identify what happens with the gut microbiota, 
we might also include this within the environmental causes of the individual and understand 
the conditioning of the disease. The first line of work is to identify if the bacterial flora plays 
a role in multiple sclerosis and the second, if it plays a role, is to determine which bacteria are 
protective and which are harmful [21, 47]. This surprising finding was made possible by the 
recent development of genetically modified mice. In the absence of exposure to any external 
influences, inflammatory reactions emerge in the brains of these animals that are similar to 
those associated with multiple sclerosis in humans, yet this only occurs when mice have intact 
gut microbiota [48]. Mice without microorganisms in their gut, which remained in a sterile 
environment, remained healthy. When vaccinated, animals bred under sterile conditions, 
with normal intestinal microorganisms, also became ill; however, the gut microbiota influ-
ences the immune systems in the digestive tract, and mice without intestinal flora have fewer 
T cells. On the other hand, the spleen of these animals produces fewer inflammatory sub-
stances, like cytokines, and, in addition, B cells produce few or no antibodies against myelin 
and restore the microbiota of mice, and their T cells and B cells increase their production of 
cytokines and antibodies [49].
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Another group of habitual commensal bacteria related to the regulation of the immune 
response and studied in EAE is lactic acid bacteria. Within this group is Pediococcus acidilac-
tici, which is administered orally and induces an IL-10 mediated response that decreases the 
severity of EAE both therapeutically and prophylactically, through the inhibition of IL-17 and 
IFN-γ and a decrease in cellular infiltrates in the CNS. In this case, the responsible, related 
lymphocytes, rather than being TCD4 + FoxP3+ (with a slight increase), were the type 1 regula-
tory T lymphocytes (Treg1) [50]. The potential use of probiotics in EAE has been investigated. 
Bifidobacterium animalis has been used during lactation of rodents that were later induced for 
EAE, with a reduction in the duration of clinical symptoms, curiously only in male mice. Using 
a combination of three strains of Lactobacillus, they demonstrated that the combination, but 
not each separately, reversed EAE in mice, associated with an increase in TregFoxP3 + lym-
phocytes and IL-4, IL-10 and TGFβ1 in the nodules of lymphatic vessels and the spleen [50]. 
Using other mixtures of probiotics (Lactobacillus, Bifidobacterium, and Streptococcus), similar 
results have been obtained, as well as the association of IL-10 and the development of Treg 
in the mechanism, which, as previously mentioned, leads to a lower polarization of lympho-
cytes T helper toward Th1/Th1 [51]. Scientists would now like to analyze the total microbial 
genome of patients with multiple sclerosis and thus identify differences in the intestinal flora 
of healthy individuals and patients with multiple sclerosis. Scientists are sure that the micro-
biota can also trigger an exaggerated reaction of the immune system against the myelin layer 
in people with a genetic predisposition for multiple sclerosis. Therefore, nutrition can play a 
central role in the disease since diet largely determines the bacteria that colonize the intestine. 
Changing eating habits could explain, for example, why the incidence of multiple sclerosis 
has increased in Asian countries in recent years. Apparently the immune system is activated 
in two stages. First, the T cells in the lymphatic vessels of the gut are activated and proliferate 
together with the proteins of the surface of the myelin layer, and these stimulate the B cells 
to form pathogenic antibodies. Both processes trigger inflammatory reactions in the brain 
that progressively destroy the myelin layer, a process that is very similar to the way multiple 
sclerosis develops in humans [52]. How does the intestinal flora influence the health of the 
brain? This is an area that arouses more and more interest in those who work with neurode-
generative diseases, and understanding this balance and how to control it can open the way to 
a new type of probiotic-based therapy (foods that contain live bacteria that may be beneficial), 
synbiotics which stimulate the growth of existing beneficial bacteria (Figure 7).
In another study, it has been shown that there is a link between intestinal commensal bacteria 
and autoimmune pathologies in murine models of MS. In one study, 34 pairs of monozygotic 
twins were selected, one ill and the other not. This choice permits eliminating the influence of 
genetic factors and reducing the environmental factors in the appearance of MS. In advance, 
they compared fecal microbiota without finding important differences, except for an excess of 
Akkermansia in untreated sick subjects. To test the functionality of these intestinal floras, they 
selected five pairs of twins. The intestinal microbiota of each individual was transferred to 
rodents predisposed to autoimmune encephalomyelitis, which is the animal model of MS. This 
transplant triggered the disease in more than 60% of the animals that received microbiota from 
subjects with MS, compared to 30% in those who received the microbiota of healthy subjects. 
The analysis of the intestinal microbiota of the transplanted animals revealed an increase of the 
Sutterella deficit in the animals that received the microbiota of subjects with MS. However, the 
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presence of this bacterium was associated with a better defense against inflammatory diseases. 
At the immune level, the study shows a deficit in the production of interleukin 10 in the ani-
mals that received the EM microbiota. In parallel, the blockade of this cytokine in rodents that 
received the healthy microbiota increased the incidence of autoimmune encephalomyelitis, 
which suggests that this molecule has a regulatory role in autoimmune diseases of the central 
nervous system [53].
5. Alteration in protein conformation: microbiota and nervous 
system
One of the problems that exist in common in several neurological diseases is alterations in 
the folding of proteins. It is the process by which the sequence of amino acids adopts a three-
dimensional structure that constitutes its native form. In some proteins, in addition to the 
native and unfolding states, there are partially folded states known as intermediates. The 
concentration of proteins in the cytoplasm is high. Despite this, proteins in the native state are 
not normally added. On the other hand, the denatured state has a very short half-life. In this 
sense, various evidences strongly suggest that the aggregation is due to the specific associa-
tion of non-native states. Several diseases that exhibit deposits of aggregated proteins have 
been associated with genetic factors, that is, point mutations in the protein that cause their 
aggregation. How do mutations facilitate aggregation? In physicochemical terms, mutations 
Figure 7. This figure shows an inflammatory pathway in mice very similar to that developed in MS patients. This 
inflammatory reaction is associated with modifications in the intestinal microbiota in mice. This image is a modification 
of QIAGEN’s at www.QIAGEN.com/es/shop/genes-and-pathways/pathway-details/?pwid=29.
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can alter the stability or speed of interconversion between the native form and the fibrillar 
form; denaturing conditions have been found that favor the presence of non-native confor-
mations, which act as precursors of the formation of the altered proteins. Another coinci-
dence that exists in several neuropathologies is that we know what is happening (not always 
everything), but the root cause, what or who initiates, is unknown; we mention that this is 
multifactorial and, in it, we cover part of our ignorance. A particular case is the stabilization 
of the folding of α-synuclein, which is involved in Parkinson’s disease, dementia associated 
with Lewy bodies, and the variant of Alzheimer’s disease also associated with Lewy bodies.
As mentioned above, a large number of proteins without homology, or not associated with 
diseases, present conformational structural alterations. If so, why are not all proteins added? 
And at this point is when we have the obligation to analyze these neuropathologies in a sys-
temic way. Our body has taken thousands of years to perfect itself, and we often forget that the 
set of systems that make up our body is a unit and that this is in constant interaction between 
its organs and systems but also with the environment and other organisms that are part of it, 
including the microbiota, which is currently telling us how there are close dialogs between 
our gut and our nervous system and other systems in a constant back and forth of informa-
tion in both directions. In most diseases described above, their diagnosis is another challenge 
because only if we are strict enough we will only say probable Parkinson’s disease, and this 
will only be corroborated with its postmortem study, the same happens with Alzheimer’s. 
When classifying these diseases, we reach another coincidence in most of them—sporadic or 
genetic—and their percentages between them are similar 85–90% vs. 15–10% (respectively). 
Where the genetic and the environment are usually variations of the same symphony, at the 
end of the day, the relationship between the nervous system and the microbiota of the gut is 
a fact that invites us to reflect on the individuality of the systems and the need for research in 
translational medicine.
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